Generative AI (GenAI) in the Pharmaceutical Industry (PowerPoint PPTX Slide Deck)

DESCRIPTION

Pharmaceutical companies recognize the immense potential of Generative AI (GenAI) to accelerate drug discovery, improve clinical trials, and optimize commercial operations. Yet, capturing real value requires moving beyond hype to structured implementation strategies.

The McKinsey Global Institute estimates that GenAI could generate $60B–$110B in annual value across the pharma industry. However, most companies are still in the early stages of adoption, struggling to move from pilot projects to enterprise-wide deployment. Success requires a clear business framework that aligns AI with strategic goals, ensures regulatory compliance, and integrates AI into core workflows.

This PPT presentation explores the real economic impact of GenAI in pharma and addresses common misconceptions that prevent adoption. It also discusses the 5 core pharma domains that will be transformed by GenAI:

1. Research & Discovery – Utilize GenAI to drive the early-stage identification and development of new pharmaceutical compounds through AI-powered knowledge extraction, compound design, and in silico screening, which involves virtual simulations to predict molecular interactions.

2. Clinical Development – Deploy GenAI solutions to streamline the design, execution, and management of clinical trials by leveraging AI for trial design, patient recruitment, regulatory intelligence, and the optimization of virtual trials.

3. Operations – Use GenAI to drive improvements around the efficiency and reliability of pharmaceutical production and logistics through AI-driven supply chain optimization, virtual manufacturing assistance, and quality control processes.

4. Commercialization – Improve the marketing and sales of pharmaceutical products by generating AI-driven marketing content, enabling sales force effectiveness, and providing personalized customer engagement strategies.

5. Medical Affairs – Support post-market activities and medical communication by facilitating AI-assisted medical writing, generating literature summaries, and producing customer insights for better stakeholder engagement.

Each of these domains is discussed in depth. This presentation also presents a structured 5-phase framework to implement and scale AI across the value chain.

This PPT presentation on GenAI in the pharma industry also includes slide templates for you to use in your own business presentations.

Got a question about the product? Email us at flevypro@flevy.com. If you cannot view the preview above this document description, go here to view the large preview instead.

Source: Best Practices in Artificial Intelligence, Pharma Industry PowerPoint Slides: Generative AI (GenAI) in the Pharmaceutical Industry PowerPoint (PPTX) Presentation Slide Deck, LearnPPT Consulting